What Is the CROB ETF? A Complete Guide to Returns, Fees, Holdings, and Alternative ETFs
This introductory article examines the structure and outlook of the CROB ETF, the Defiance China Robotics ETF, which focuses on China's humanoid robot ecosystem. From a long-term perspective, it reviews the index-tracking approach, industry concentration, and the risks tied to the Chinese market and currency fluctuations.
What Is the Defiance China Robotics ETF?
The CROB ETF is a passive product designed to pursue the performance of the Solactive China Humanoid Robotics Index. The index uses a rules-based approach to select companies involved in the development, manufacturing, and technology supply of humanoid robots in China.
It suits investors who want long-term participation in the supply chain and technology commercialization of China's robotics industry and who can tolerate the volatility that comes with country and industry concentration.
It is an ETF managed by Defiance ETFs using a passive (index-tracking) approach.
How Does the Defiance China Robotics ETF Invest?
| Item | Details |
|---|---|
| Tracked index | Solactive China Humanoid Robotics Index |
| Management style | Passive index tracking |
| Rebalancing frequency | Follows the index methodology |
| Dividend frequency | No distribution history |
| Total expense ratio | 0.89% |
This product provides index exposure covering the manufacturing, automation, and component technologies associated with building humanoid robots in China. Rather than picking individual companies, it adjusts its holdings as the index composition changes, so changes in the industry ecosystem can influence performance more than the results of any single company.
- Focus on China's humanoid robot ecosystem
- Rules-based index tracking
Defiance China Robotics ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $2.2M, and the total expense ratio is 0.89% per year.
As a recently launched product, the CROB ETF calls for checking trading liquidity, bid-ask spreads, and any gap between net asset value and market price before you trade. The time difference of underlying assets traded on overseas exchanges can also affect the market price.
Defiance China Robotics ETF Performance and Trends
Because the CROB ETF is a recently launched product, it is difficult to judge it by a long performance history alone. Expectations for the commercialization of humanoid robots, demand for manufacturing automation, and investor sentiment toward related technology investment can influence its price movements, and swings may be large given the nature of a thematic industry.
Fund flows may vary with sentiment toward China's technology industry, access to the local market, and the risk appetite of overseas investors. Differences in trading hours between the Chinese and Hong Kong markets, market liquidity, and currency fluctuations can affect the gap between the CROB ETF's market price and its net asset value.
Defiance China Robotics ETF Strengths and Weaknesses
Concentrated access to China's robotics supply chain is a strength, but country and industry concentration and the trading conditions typical of a recently launched product deserve attention.
💪 Key Strengths
⚠️ Points to Watch
Defiance China Robotics ETF Alternatives and Related Products
Because no comparable peer candidates were provided for a comparison table of similar products, this article does not cite other ETF tickers. When reviewing alternatives, it is important to compare the level of concentration in the China robotics theme, the scope of humanoid robotics and automation coverage, the index construction method, the structure of overseas market access, and fees and trading conditions together. Because this product offers China-focused exposure to a specific theme, the risks and role you can expect from it may differ from those of broad equity market products.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| iShares MSCI EAFE Value ETF | $79.42 | +0.2% | $30.5B | 0.33% | 4.6% | +16.7% | |
| Schwab Fundamental International Equity ETF | $54.13 | +0.2% | $25.6B | 0.25% | 3.02% | +24.1% | |
| Avantis International Small Cap Value ETF | $107.78 | +0.2% | $20.0B | 0.36% | 3.22% | +22.2% | |
| iShares MSCI EAFE Growth ETF | $119.98 | +0.5% | $15.0B | 0.36% | 2.32% | +2.9% | |
| iShares A.I. Innovation and Tech Active ETF | $42.89 | +1.9% | $13.1B | 0.55% | 1.38% | +23.1% |
Defiance China Robotics ETF Investor Checkpoints
Before investing, you should first decide what role the China robotics industry theme will play in your overall asset allocation. Checking the tracked index and management approach, the trading environment, currency exposure, and the absence of distribution history together can help you separate expectations from risks more clearly.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| Investment strategy | Index construction criteria and theme scope | Review disclosure documents |
| Trading environment | Bid-ask spread and market price gap | Check before trading |
| Diversification | Concentration in China and the robotics industry | Concentrated exposure |
| Distribution policy | Distribution history and cash flow expectations | No distribution history |
The pace of robotics commercialization, the burden of research and development, and changes in the competitive landscape can affect the valuation of the included companies and of the theme as a whole. Regulatory changes in the Chinese and Hong Kong markets, geopolitical variables, currency fluctuations, and local trading hour differences can widen the gap between market price and net asset value.
The Defiance China Robotics ETF is a passive product suited to those who want to focus on China's humanoid robot ecosystem. However, it is more appropriate to approach it as a thematic allocation rather than a substitute for a broadly diversified product, and to first review the trading environment and the risks of country and industry concentration.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of August 20, 2026.